nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—HTR1E—forebrain—attention deficit hyperactivity disorder	0.0191	0.163	CbGeAlD
Ergonovine—HTR1E—nervous system—attention deficit hyperactivity disorder	0.0104	0.0883	CbGeAlD
Ergonovine—HTR1E—central nervous system—attention deficit hyperactivity disorder	0.01	0.085	CbGeAlD
Ergonovine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00868	0.0737	CbGeAlD
Ergonovine—HTR1E—brain—attention deficit hyperactivity disorder	0.00794	0.0675	CbGeAlD
Ergonovine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00673	0.0572	CbGeAlD
Ergonovine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.00573	0.0487	CbGeAlD
Ergonovine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.00569	0.0484	CbGeAlD
Ergonovine—Pergolide—DRD5—attention deficit hyperactivity disorder	0.0051	0.0649	CrCbGaD
Ergonovine—Pergolide—ADRA2C—attention deficit hyperactivity disorder	0.00481	0.0612	CrCbGaD
Ergonovine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.00471	0.04	CbGeAlD
Ergonovine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.00453	0.0385	CbGeAlD
Ergonovine—Lisuride—DRD5—attention deficit hyperactivity disorder	0.00443	0.0563	CrCbGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0042	0.00522	CbGpPWpGaD
Ergonovine—Lisuride—ADRA2C—attention deficit hyperactivity disorder	0.00418	0.0531	CrCbGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00413	0.00514	CbGpPWpGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00412	0.00513	CbGpPWpGaD
Ergonovine—Bromocriptine—DRD5—attention deficit hyperactivity disorder	0.0041	0.0522	CrCbGaD
Ergonovine—HTR1E—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0041	0.0051	CbGpPWpGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00407	0.00507	CbGpPWpGaD
Ergonovine—Bromocriptine—ADRA2C—attention deficit hyperactivity disorder	0.00387	0.0492	CrCbGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00379	0.00472	CbGpPWpGaD
Ergonovine—HTR2C—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00372	0.00463	CbGpPWpGaD
Ergonovine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.00365	0.0311	CbGeAlD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00361	0.00449	CbGpPWpGaD
Ergonovine—HTR2C—brain—attention deficit hyperactivity disorder	0.0036	0.0306	CbGeAlD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00354	0.0044	CbGpPWpGaD
Ergonovine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.00352	0.0299	CbGeAlD
Ergonovine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.00344	0.0292	CbGeAlD
Ergonovine—ADRA1A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00316	0.00393	CbGpPWpGaD
Ergonovine—HTR2C—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00313	0.00389	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00308	0.00384	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00286	0.00356	CbGpPWpGaD
Ergonovine—Methylergometrine—DRD1—attention deficit hyperactivity disorder	0.00286	0.0364	CrCbGaD
Ergonovine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00285	0.0242	CbGeAlD
Ergonovine—ADRA1A—brain—attention deficit hyperactivity disorder	0.00279	0.0237	CbGeAlD
Ergonovine—HTR1E—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00275	0.00342	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00269	0.00335	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00269	0.00335	CbGpPWpGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00266	0.00331	CbGpPWpGaD
Ergonovine—Pergolide—DRD4—attention deficit hyperactivity disorder	0.00261	0.0332	CrCbGaD
Ergonovine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00251	0.00312	CbGpPWpGaD
Ergonovine—Methysergide—HTR1B—attention deficit hyperactivity disorder	0.0025	0.0319	CrCbGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0025	0.00311	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00245	0.00305	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00243	0.00302	CbGpPWpGaD
Ergonovine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00241	0.0205	CbGeAlD
Ergonovine—HTR1E—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00239	0.00297	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00236	0.00293	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00233	0.00289	CbGpPWpGaD
Ergonovine—Pergolide—HTR1B—attention deficit hyperactivity disorder	0.00232	0.0295	CrCbGaD
Ergonovine—HTR1E—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00232	0.00288	CbGpPWpGaD
Ergonovine—Lisuride—DRD4—attention deficit hyperactivity disorder	0.00227	0.0288	CrCbGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00225	0.0028	CbGpPWpGaD
Ergonovine—Pergolide—DRD3—attention deficit hyperactivity disorder	0.00225	0.0286	CrCbGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00221	0.00275	CbGpPWpGaD
Ergonovine—Pergolide—DRD1—attention deficit hyperactivity disorder	0.00221	0.0281	CrCbGaD
Ergonovine—HTR1E—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00219	0.00273	CbGpPWpGaD
Ergonovine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00219	0.0186	CbGeAlD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00219	0.00272	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00214	0.00267	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00212	0.00264	CbGpPWpGaD
Ergonovine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00211	0.0179	CbGeAlD
Ergonovine—HTR1E—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0021	0.00262	CbGpPWpGaD
Ergonovine—Bromocriptine—DRD4—attention deficit hyperactivity disorder	0.0021	0.0267	CrCbGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00208	0.00258	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00206	0.00257	CbGpPWpGaD
Ergonovine—Pergolide—ADRA2A—attention deficit hyperactivity disorder	0.00205	0.0261	CrCbGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00204	0.00253	CbGpPWpGaD
Ergonovine—Lisuride—HTR1B—attention deficit hyperactivity disorder	0.00201	0.0256	CrCbGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00199	0.00248	CbGpPWpGaD
Ergonovine—Lisuride—DRD3—attention deficit hyperactivity disorder	0.00195	0.0249	CrCbGaD
Ergonovine—Ergotamine—HTR1B—attention deficit hyperactivity disorder	0.00193	0.0246	CrCbGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00193	0.0024	CbGpPWpGaD
Ergonovine—Lisuride—DRD1—attention deficit hyperactivity disorder	0.00192	0.0244	CrCbGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0019	0.00236	CbGpPWpGaD
Ergonovine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00188	0.016	CbGeAlD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00187	0.00233	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00187	0.00232	CbGpPWpGaD
Ergonovine—Bromocriptine—HTR1B—attention deficit hyperactivity disorder	0.00186	0.0237	CrCbGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00182	0.00226	CbGpPWpGaD
Ergonovine—Bromocriptine—DRD3—attention deficit hyperactivity disorder	0.00181	0.023	CrCbGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0018	0.00224	CbGpPWpGaD
Ergonovine—Lisuride—ADRA2A—attention deficit hyperactivity disorder	0.00178	0.0227	CrCbGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00178	0.00221	CbGpPWpGaD
Ergonovine—Bromocriptine—DRD1—attention deficit hyperactivity disorder	0.00178	0.0226	CrCbGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00177	0.0022	CbGpPWpGaD
Ergonovine—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00177	0.0022	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00175	0.00218	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00174	0.00217	CbGpPWpGaD
Ergonovine—Ergotamine—ADRA2A—attention deficit hyperactivity disorder	0.00171	0.0218	CrCbGaD
Ergonovine—Bromocriptine—ADRA2A—attention deficit hyperactivity disorder	0.00165	0.021	CrCbGaD
Ergonovine—HTR1E—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00163	0.00203	CbGpPWpGaD
Ergonovine—Pergolide—DRD2—attention deficit hyperactivity disorder	0.00156	0.0198	CrCbGaD
Ergonovine—Methylergometrine—HTR2A—attention deficit hyperactivity disorder	0.00156	0.0198	CrCbGaD
Ergonovine—HTR1E—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00155	0.00193	CbGpPWpGaD
Ergonovine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00155	0.0132	CbGeAlD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00154	0.00192	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00152	0.00189	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00152	0.00189	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00151	0.00188	CbGpPWpGaD
Ergonovine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00149	0.0127	CbGeAlD
Ergonovine—HTR1E—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00147	0.00183	CbGpPWpGaD
Ergonovine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00146	0.0124	CbGeAlD
Ergonovine—HTR1E—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00144	0.0018	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00144	0.00179	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00143	0.00177	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00143	0.00177	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00141	0.00176	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00138	0.00172	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00138	0.00172	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00135	0.00169	CbGpPWpGaD
Ergonovine—Lisuride—DRD2—attention deficit hyperactivity disorder	0.00135	0.0172	CrCbGaD
Ergonovine—HTR1E—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00133	0.00165	CbGpPWpGaD
Ergonovine—Methysergide—HTR2A—attention deficit hyperactivity disorder	0.0013	0.0165	CrCbGaD
Ergonovine—Ergotamine—DRD2—attention deficit hyperactivity disorder	0.0013	0.0165	CrCbGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00126	0.00157	CbGpPWpGaD
Ergonovine—Bromocriptine—DRD2—attention deficit hyperactivity disorder	0.00125	0.0159	CrCbGaD
Ergonovine—HTR1E—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00124	0.00155	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00123	0.00153	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00122	0.00152	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00122	0.00152	CbGpPWpGaD
Ergonovine—Pergolide—HTR2A—attention deficit hyperactivity disorder	0.0012	0.0153	CrCbGaD
Ergonovine—ABCB1—brain—attention deficit hyperactivity disorder	0.00118	0.0101	CbGeAlD
Ergonovine—ADRA1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00118	0.00146	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00117	0.00146	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00117	0.00145	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00115	0.00143	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00113	0.00141	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00111	0.00139	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0011	0.00137	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00108	0.00134	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00107	0.00133	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00106	0.00132	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00105	0.00131	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00105	0.0013	CbGpPWpGaD
Ergonovine—Lisuride—HTR2A—attention deficit hyperactivity disorder	0.00104	0.0133	CrCbGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00102	0.00127	CbGpPWpGaD
Ergonovine—Ergotamine—HTR2A—attention deficit hyperactivity disorder	0.001	0.0128	CrCbGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.001	0.00125	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000995	0.00124	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000991	0.00123	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000971	0.00121	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00097	0.00121	CbGpPWpGaD
Ergonovine—Bromocriptine—HTR2A—attention deficit hyperactivity disorder	0.000968	0.0123	CrCbGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000963	0.0012	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000958	0.00119	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000954	0.00119	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000947	0.00118	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000942	0.00117	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000939	0.00117	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000935	0.00116	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000931	0.00116	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000928	0.00115	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000922	0.00115	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000917	0.00114	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0009	0.00112	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000878	0.00109	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000871	0.00108	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000857	0.00107	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000852	0.00106	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000837	0.00104	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000833	0.00104	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00083	0.00103	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00083	0.00103	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000827	0.00103	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000825	0.00103	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000821	0.00102	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000816	0.00102	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000816	0.00102	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000811	0.00101	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000806	0.001	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000801	0.000997	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000801	0.000996	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000798	0.000993	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000789	0.000982	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000789	0.000981	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000782	0.000972	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000778	0.000969	CbGpPWpGaD
Ergonovine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000771	0.00096	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000766	0.000953	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000763	0.000949	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000754	0.000938	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000751	0.000934	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000746	0.000929	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000741	0.000922	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000739	0.00092	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000732	0.000911	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000726	0.000904	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000718	0.000893	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000717	0.000893	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00071	0.000883	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000706	0.000878	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000698	0.000868	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000695	0.000865	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000682	0.000848	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000668	0.000832	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000665	0.000827	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000651	0.00081	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000649	0.000807	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000628	0.000782	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000625	0.000778	CbGpPWpGaD
Ergonovine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000618	0.000769	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000618	0.000769	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000615	0.000765	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00061	0.000759	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00061	0.000759	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000603	0.000751	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000591	0.000736	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00059	0.000734	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000568	0.000707	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000566	0.000704	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000531	0.000661	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000531	0.00066	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000526	0.000654	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000523	0.00065	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000495	0.000615	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000488	0.000607	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000482	0.0006	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000478	0.000594	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000468	0.000582	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000464	0.000577	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00046	0.000572	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000451	0.000561	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000445	0.000554	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000438	0.000545	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000432	0.000538	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000431	0.000537	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000421	0.000524	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000419	0.000522	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000418	0.00052	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000415	0.000516	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000413	0.000513	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000411	0.000511	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000411	0.000511	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00041	0.00051	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00041	0.00051	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000407	0.000506	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000405	0.000504	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000403	0.000501	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000403	0.000501	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000398	0.000495	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000394	0.000491	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000392	0.000487	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000379	0.000472	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000378	0.00047	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000373	0.000464	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000368	0.000458	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000367	0.000456	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000358	0.000446	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000356	0.000444	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000355	0.000442	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000349	0.000435	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000349	0.000434	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000345	0.000429	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000343	0.000427	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000342	0.000426	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000333	0.000414	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000322	0.000401	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000321	0.0004	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000317	0.000394	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000313	0.00039	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000292	0.000363	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000288	0.000358	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000285	0.000354	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000282	0.000351	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000274	0.000341	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000265	0.000329	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000264	0.000329	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000249	0.00031	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000242	0.000301	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00024	0.000299	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000231	0.000288	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000225	0.00028	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000224	0.000279	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00022	0.000274	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000218	0.000271	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000212	0.000263	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000204	0.000254	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000203	0.000252	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000197	0.000245	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000191	0.000237	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000189	0.000235	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000189	0.000235	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000187	0.000233	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000186	0.000231	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000185	0.00023	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000173	0.000215	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000172	0.000214	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000169	0.00021	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000151	0.000188	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000149	0.000186	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000144	0.000179	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000142	0.000177	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000121	0.00015	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000116	0.000145	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000116	0.000145	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000115	0.000143	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000115	0.000143	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000114	0.000142	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000107	0.000133	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.31e-05	0.000116	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.86e-05	0.00011	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.52e-05	9.35e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.06e-05	8.78e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.01e-05	8.72e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.39e-05	7.95e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.91e-05	6.11e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.03e-05	3.77e-05	CbGpPWpGaD
